Revenue: The sum of all revenue fields included for a company's operating activities.
Immunovant, Inc. (IMVT) Revenue data is not available.
| Income Statement Financials | |
|
Revenue |
-- |
$-51.42M |
|
-- |
|
-- |
|
$61.55M |
|
$-61.55M |
|
$10.03M |
|
$-51.53M |
|
$-51.53M |
|
$-51.42M |
|
$-51.42M |
|
$-51.42M |
|
$-51.42M |
|
$-61.55M |
|
$-61.49M |
|
144.52M |
|
144.52M |
|
$-0.36 |
|
$-0.36 |
|
| Balance Sheet Financials | |
$710.78M |
|
$0.38M |
|
$0.67M |
|
$711.45M |
|
$32.10M |
|
-- |
|
-- |
|
$32.10M |
|
$679.34M |
|
$679.34M |
|
$679.34M |
|
145.09M |
|
| Cash Flow Statement Financials | |
$-154.53M |
|
$-0.21M |
|
$470.88M |
|
$376.53M |
|
$690.94M |
|
$314.40M |
|
$31.44M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
22.14 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-154.74M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-7.57% |
|
-7.57% |
|
-7.23% |
|
-7.57% |
|
$4.68 |
|
$-1.07 |
|
$-1.07 |
|